https://www.uuuwell.com/article-1969887-1.html “We basically have a tool that mimics the genetic mutation of CCR5 that made some people immune to infection and to some extent cured 2 HIV cases. The results of preclinical studies targeting the HIV co-receptor CCR5 have Breakthrough potential," said Liomwa Ndhlovu, MD